Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
Zhen-Yu XianYi-Wen SongZong-Jin ZhangYing-Guo GanYong-Le ChenTuo HuXiao-Feng WenTai-Wei MoXiao-Wen HePublished in: World journal of surgical oncology (2024)
Combined PRFs improved the risk stratification of low-risk stage III CC, which could reduce the incidence of undertreatment and guide adjuvant chemotherapy.